Pregnancy places unique physiological demands on the respiratory system, as hormonal and mechanical changes alter lung function, oxygen consumption, and breathing patterns. Women with pre-existing respiratory conditions, such as asthma or cystic fibrosis, often face an increased risk of complications including preterm birth, low birth weight, and hypertensive disorders. Even in otherwise healthy women, respiratory infections can lead to severe maternal and neonatal outcomes if not promptly recognized and managed. Access to routine prenatal care that includes respiratory assessment is crucial to minimizing these risks.
The approach to managing lung health during pregnancy relies on careful balancing of maternal treatment with fetal safety. Medication regimens are often adjusted to minimize teratogenic risks while still maintaining adequate disease control, as poorly managed respiratory illness can pose greater harm than pharmacologic exposure. Preventive strategies, including vaccination, smoking cessation support, and environmental hazard reduction, are strongly emphasized. Multidisciplinary care teams that include obstetricians, pulmonologists, and neonatal specialists play a key role in guiding treatment decisions, educating expectant mothers, and preparing for safe deliveries. As research advances, new insights into maternal-fetal interactions continue to shape best practices, improving both respiratory outcomes and long-term child health.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation